MAP ≈ aortic pressure; primary goals of regulation:
Keep MAP at its homeostatic set-point to guarantee adequate systemic perfusion.
Secondarily adjust MAP to optimize O₂ transport and blood pH (H⁺ balance).
Core effector organs: heart, systemic blood vessels, kidneys.
All classic control loops need:
Sensors – continually monitor the variable.
Integrating center – compares current values with set-points.
Effectors – receive commands and restore balance.
Variable list relevant here:
\text{MAP}, [\text{O}2]{blood}, \text{pH}_{blood}\;(\propto\;[\text{H}^+]).
Location & functional niches:
Aortic arch – directly measures MAP ("central gauge").
Carotid sinuses (bulges of the common carotids) – back-up MAP gauge & guardian of cerebral perfusion.
Afferent pathways:
Aortic arch → Vagus n. (CN X).
Carotid sinus → Glossopharyngeal n. (CN IX).
Embedded in walls of the superior & inferior venae cavae and right-atrial junction.
Pressure is extremely low; primary information conveyed = total blood volume status rather than MAP.
Co-located with baroreceptors.
Detect:
\text{O}_2 saturation (hypoxia).
(\text{pH}) via [\text{H}^+] (indirect monitor of \text{CO}2 because \text{CO}2+\text{H}2\text{O} \leftrightarrow \text{H}^++\text{HCO}3^-).
Afferents run through same cranial nerves as baroreceptors.
Contains gray-matter cardiovascular control centers:
Cardiac center
Cardiac Accelerator Center (CAC) – sympathetic.
Cardiac Inhibitory Center (CIC) – parasympathetic.
Vasomotor center
Vasoconstrictor sub-center – sympathetic.
Vasodilator sub-center – inhibits sympathetic outflow to allow dilation.
Always compares incoming sensory traffic with set-points and selects autonomic output pattern.
Additional (non-exam) inputs: proprioceptors (movement), higher brain areas (cortex, limbic, hypothalamus – emotional pressure changes).
Cardiac accelerator nerves → SA/AV nodes & myocardium → ↑ HR & ↑ contractility.
Sympathetic vasomotor nerves → vascular smooth muscle → vasoconstriction (raising TPR).
Stimulus transmitter: norepinephrine (NE).
Vagus nerve (CN X) → SA/AV nodes → ↓ HR (via muscarinic ACh receptors); minimal effect on ventricular contractility.
Virtually no direct parasympathetic innervation of systemic arterioles (hence vessel tone is mainly a function of sympathetic activity).
\text{MAP}=\text{CO}\times \text{TPR}.
\text{CO}=\text{HR}\times\text{SV} (stroke volume depends on contractility, preload, afterload).
↑ MAP → ↑ baroreceptor firing → medulla:
↓ CAC & vasoconstrictor activity (↓ sympathetic).
↑ CIC & vasodilator activity (↑ parasympathetic to heart).
Net → ↓ HR, ↓ contractility, vasodilation → ↓ MAP back toward set-point.
↓ MAP triggers the opposite cascade.
Trigger conditions: ↓ O₂, ↓ pH (↑ H⁺, typically via ↑ CO₂).
Goal: raise MAP to accelerate perfusion of lungs & tissues.
Medullary output:
↑ sympathetic (CAC & vasoconstrictor) → ↑ CO & ↑ TPR → ↑ MAP.
Often coupled with respiratory center activation → ↑ ventilation (expels (\text{CO}_2), raises O₂).
Receptor | Location | Agonist | Effect |
---|---|---|---|
\beta_1 | Myocardium (SA, AV, ventricles) | NE & Epi | ↑ HR, ↑ contractility |
\beta_2 | Vascular smooth muscle of heart & skeletal muscle arterioles; airway smooth muscle | Epi ≫ NE | Vasodilation; bronchodilation |
\alpha_1 | Most systemic arterioles (skin, gut, kidney, etc.) | NE & Epi | Vasoconstriction |
Muscarinic (M₂) | Heart nodes | ACh (parasym.) | ↓ HR |
Mechanistic note:
Mixed distribution in muscle arterioles: \alpha1 causes constriction but \beta2 predominates → net dilation during generalized sympathetic discharge ("fight-or-flight" shunt of blood to muscles & heart).
Catecholamines (Epi/NE) – mirror autonomic actions; released from adrenal medulla when sympathetic activity spikes.
Vasoconstrictors (raise TPR & MAP):
Antidiuretic hormone (ADH/vasopressin)
Angiotensin II
Aldosterone (indirect via Na⁺/water retention)
Vasodilator: Atrial natriuretic peptide (ANP)
Filters plasma; variable water reabsorption sets blood volume (BV).
ADH is principal short-to-medium term hormone:
Stimulus: ↓ MAP or ↑ osmolarity.
Effect: ↑ water reabsorption → ↓ urine output → ↑ BV → ↑ MAP.
Bonus: ADH also produces vasoconstriction (V₁ receptors) – “pressin” aspect.
Over hours–days, the renin-angiotensin-aldosterone system (RAAS) adds Na⁺ retention & further vasoconstriction.
Hemorrhage → ↓ BV → ↓ venous pressure (volume receptors) & ↓ MAP (baroreceptors).
Reflex: Massive sympathetic discharge → ↑ HR/contractility, vasoconstriction, RAAS & ADH activation → restores pressure & volume.
High-intensity sprint (exercise)
Proprioceptors + cortex anticipate demand → ↑ sympathetic tone even before MAP drops.
Targeted dilation in muscle arterioles (β₂) despite global sympathetic-mediated vasoconstriction elsewhere.
Hypercapnia (↑ CO₂)/Acidosis
Chemoreceptors → ↑ MAP + ↑ ventilation; faster pulmonary circulation allows more rapid CO₂ off-loading and O₂ loading, ameliorating pH.
Autonomic blockers (β-blockers, α-blockers) exploit receptor specificity to treat hypertension, arrhythmias, pheochromocytoma.
Over-aggressive vasoconstriction (ex: septic vasopressors, cocaine) risks ischemia in tissues lacking β₂ escape.
Understanding low-pressure receptors guides fluid resuscitation strategy vs. vasopressor selection in shock management.
\text{MAP} = \text{CO} \times \text{TPR}.
Normal systemic arterial MAP: \approx 93\;\text{mmHg} (calculated as \text{DP} + \frac{1}{3}(\text{SP}-\text{DP})).
Venous (central) pressure: \approx 2\;\text{–}\;5\;\text{mmHg} → foundation for calling venous sensors “low-pressure”.
Typical reflex latency: baroreceptor response within 1–2 heartbeats; hormonal/renal responses minutes–hours.